TapImmune Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | TapImmune Inc.

TapImmune Inc. | Ownership

Companies that own TapImmune Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Eastern Capital Ltd.

3,633,334

26.67%

1,300,000

10.24%

05/14/2018

Iroquois Capital Management LLC

382,754

2.81%

12.47%

04/04/2018

Driehaus Capital Management LLC

333,093

2.44%

333,093

0.06%

06/30/2018

Heights Capital Management, Inc.

250,000

1.84%

250,000

0.06%

06/30/2018

683 Capital Management LLC

200,000

1.47%

200,000

0.2%

06/30/2018

RTW Investments LP

200,000

1.47%

200,000

0.1%

06/30/2018

The Vanguard Group, Inc.

187,204

1.37%

52,602

06/30/2018

Caxton Corp.

84,674

0.62%

84,674

0.73%

06/30/2018

Geode Capital Management LLC

43,426

0.32%

43,426

06/30/2018

Myda Advisors LLC

39,801

0.28%

39,801

0.28%

06/30/2018

About TapImmune

View Profile

Address	5 West Forsyth Street Jacksonville Florida 32202 United States
Employees	-
Website	http://www.tapimmune.com
Updated	09/14/2018
TapImmune, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.